The REZA BAND applies slight pressure to the neck to reduce laryngopharyngeal reflux symptoms. In clinical trials, 86 percent of patients were found to have significant symptom reduction after two weeks, according to the report.
Reza Shaker, MD, chief of gastroenterology and hepatology at Froedtert & The Medical College of Wisconsin in Milwaukee, is one of the founders of Somna Therapeutics.
More articles on gastroenterology:
26 gastroenterologists making headlines – March 10, 2015
Exact Sciences, Ironwood Pharmaceuticals partner for promotion of Cologuard
Gastroenterology technology company to know: Exalenz Bioscience
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
